Functional outcome and quality of life in adult congenital heart disease patients with prosthetic valves*

Functional outcome and quality of life in adult congenital heart disease patients with prosthetic valves* - Prostava

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32722

Enrollment

600

Registered

2010-05-21

Start date

2010-11-13

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prosthetic heart valves in congenital heart disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Included in concor database, congenital heart disease, valve prosthesis 9all required)

Exclusion criteria

Exclusion criteria: Inability to comply with examinations (quality of life questionnaire and exercise test)

Design outcomes

Primary

Measure	Time frame
Primary outcomes are VO2max and quality of life.	—

Secondary

Measure	Time frame
Secondary outcomes are the prevalence of PPM and the incidence of valve related complications.	—

Countries

Netherlands

Outcome results